Global Lung Cancer Diagnostic And Screening Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Lung Cancer Diagnostic And Screening Market Size was estimated at USD 80.49 million in 2023 and is projected to reach USD 105.42 million by 2029, exhibiting a CAGR of 4.60% during the forecast period.
This report provides a deep insight into the global Lung Cancer Diagnostic And Screening market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Lung Cancer Diagnostic And Screening Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Lung Cancer Diagnostic And Screening market in any manner.
Global Lung Cancer Diagnostic And Screening Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
F.Hoffmann-La Roche AG
Bristol-Myers Squibb Company
Thermo Fisher Scientific
AstraZeneca Plc
Abbott Laboratories
Medtronic Plc
Danaher Corporation
Siemens Healthcare GmbH
FUJIFILM Corporation
KoninklijikePhilips N.V.
GE Healthcare Bio Sciences AB
Quest Diagnostics lIncorporated
Agilent Technologies lnc
Qiagen Inc.
Myriad Genetic Laboratories Inc.
NeoGenomics Laboratories Inc
Canon MedicalSystems Corporation
Eon Health Inc
Market Segmentation (by Type)
Instrument
Consumables and Accessories
Market Segmentation (by Application)
Hospital
Independent Diagnostic Laboratory
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Diagnostic And Screening Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Lung Cancer Diagnostic And Screening Market Size was estimated at USD 80.49 million in 2023 and is projected to reach USD 105.42 million by 2029, exhibiting a CAGR of 4.60% during the forecast period.
This report provides a deep insight into the global Lung Cancer Diagnostic And Screening market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Lung Cancer Diagnostic And Screening Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Lung Cancer Diagnostic And Screening market in any manner.
Global Lung Cancer Diagnostic And Screening Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
F.Hoffmann-La Roche AG
Bristol-Myers Squibb Company
Thermo Fisher Scientific
AstraZeneca Plc
Abbott Laboratories
Medtronic Plc
Danaher Corporation
Siemens Healthcare GmbH
FUJIFILM Corporation
KoninklijikePhilips N.V.
GE Healthcare Bio Sciences AB
Quest Diagnostics lIncorporated
Agilent Technologies lnc
Qiagen Inc.
Myriad Genetic Laboratories Inc.
NeoGenomics Laboratories Inc
Canon MedicalSystems Corporation
Eon Health Inc
Market Segmentation (by Type)
Instrument
Consumables and Accessories
Market Segmentation (by Application)
Hospital
Independent Diagnostic Laboratory
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Lung Cancer Diagnostic And Screening Market
- Overview of the regional outlook of the Lung Cancer Diagnostic And Screening Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Diagnostic And Screening Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Lung Cancer Diagnostic And Screening
1.2 Key Market Segments
1.2.1 Lung Cancer Diagnostic And Screening Segment by Type
1.2.2 Lung Cancer Diagnostic And Screening Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LUNG CANCER DIAGNOSTIC AND SCREENING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LUNG CANCER DIAGNOSTIC AND SCREENING MARKET COMPETITIVE LANDSCAPE
3.1 Global Lung Cancer Diagnostic And Screening Revenue Market Share by Company (2019-2024)
3.2 Lung Cancer Diagnostic And Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Lung Cancer Diagnostic And Screening Market Size Sites, Area Served, Product Type
3.4 Lung Cancer Diagnostic And Screening Market Competitive Situation and Trends
3.4.1 Lung Cancer Diagnostic And Screening Market Concentration Rate
3.4.2 Global 5 and 10 Largest Lung Cancer Diagnostic And Screening Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 LUNG CANCER DIAGNOSTIC AND SCREENING VALUE CHAIN ANALYSIS
4.1 Lung Cancer Diagnostic And Screening Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LUNG CANCER DIAGNOSTIC AND SCREENING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 LUNG CANCER DIAGNOSTIC AND SCREENING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Diagnostic And Screening Market Size Market Share by Type (2019-2024)
6.3 Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Type (2019-2024)
7 LUNG CANCER DIAGNOSTIC AND SCREENING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Diagnostic And Screening Market Size (M USD) by Application (2019-2024)
7.3 Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Application (2019-2024)
8 LUNG CANCER DIAGNOSTIC AND SCREENING MARKET SEGMENTATION BY REGION
8.1 Global Lung Cancer Diagnostic And Screening Market Size by Region
8.1.1 Global Lung Cancer Diagnostic And Screening Market Size by Region
8.1.2 Global Lung Cancer Diagnostic And Screening Market Size Market Share by Region
8.2 North America
8.2.1 North America Lung Cancer Diagnostic And Screening Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Lung Cancer Diagnostic And Screening Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Lung Cancer Diagnostic And Screening Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Lung Cancer Diagnostic And Screening Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Lung Cancer Diagnostic And Screening Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer Lung Cancer Diagnostic And Screening Basic Information
9.1.2 Pfizer Lung Cancer Diagnostic And Screening Product Overview
9.1.3 Pfizer Lung Cancer Diagnostic And Screening Product Market Performance
9.1.4 Pfizer Lung Cancer Diagnostic And Screening SWOT Analysis
9.1.5 Pfizer Business Overview
9.1.6 Pfizer Recent Developments
9.2 F.Hoffmann-La Roche AG
9.2.1 F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Basic Information
9.2.2 F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Product Overview
9.2.3 F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Product Market Performance
9.2.4 Pfizer Lung Cancer Diagnostic And Screening SWOT Analysis
9.2.5 F.Hoffmann-La Roche AG Business Overview
9.2.6 F.Hoffmann-La Roche AG Recent Developments
9.3 Bristol-Myers Squibb Company
9.3.1 Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Basic Information
9.3.2 Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Product Overview
9.3.3 Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Product Market Performance
9.3.4 Pfizer Lung Cancer Diagnostic And Screening SWOT Analysis
9.3.5 Bristol-Myers Squibb Company Business Overview
9.3.6 Bristol-Myers Squibb Company Recent Developments
9.4 Thermo Fisher Scientific
9.4.1 Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Basic Information
9.4.2 Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Product Overview
9.4.3 Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Product Market Performance
9.4.4 Thermo Fisher Scientific Business Overview
9.4.5 Thermo Fisher Scientific Recent Developments
9.5 AstraZeneca Plc
9.5.1 AstraZeneca Plc Lung Cancer Diagnostic And Screening Basic Information
9.5.2 AstraZeneca Plc Lung Cancer Diagnostic And Screening Product Overview
9.5.3 AstraZeneca Plc Lung Cancer Diagnostic And Screening Product Market Performance
9.5.4 AstraZeneca Plc Business Overview
9.5.5 AstraZeneca Plc Recent Developments
9.6 Abbott Laboratories
9.6.1 Abbott Laboratories Lung Cancer Diagnostic And Screening Basic Information
9.6.2 Abbott Laboratories Lung Cancer Diagnostic And Screening Product Overview
9.6.3 Abbott Laboratories Lung Cancer Diagnostic And Screening Product Market Performance
9.6.4 Abbott Laboratories Business Overview
9.6.5 Abbott Laboratories Recent Developments
9.7 Medtronic Plc
9.7.1 Medtronic Plc Lung Cancer Diagnostic And Screening Basic Information
9.7.2 Medtronic Plc Lung Cancer Diagnostic And Screening Product Overview
9.7.3 Medtronic Plc Lung Cancer Diagnostic And Screening Product Market Performance
9.7.4 Medtronic Plc Business Overview
9.7.5 Medtronic Plc Recent Developments
9.8 Danaher Corporation
9.8.1 Danaher Corporation Lung Cancer Diagnostic And Screening Basic Information
9.8.2 Danaher Corporation Lung Cancer Diagnostic And Screening Product Overview
9.8.3 Danaher Corporation Lung Cancer Diagnostic And Screening Product Market Performance
9.8.4 Danaher Corporation Business Overview
9.8.5 Danaher Corporation Recent Developments
9.9 Siemens Healthcare GmbH
9.9.1 Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Basic Information
9.9.2 Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Product Overview
9.9.3 Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Product Market Performance
9.9.4 Siemens Healthcare GmbH Business Overview
9.9.5 Siemens Healthcare GmbH Recent Developments
9.10 FUJIFILM Corporation
9.10.1 FUJIFILM Corporation Lung Cancer Diagnostic And Screening Basic Information
9.10.2 FUJIFILM Corporation Lung Cancer Diagnostic And Screening Product Overview
9.10.3 FUJIFILM Corporation Lung Cancer Diagnostic And Screening Product Market Performance
9.10.4 FUJIFILM Corporation Business Overview
9.10.5 FUJIFILM Corporation Recent Developments
9.11 KoninklijikePhilips N.V.
9.11.1 KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Basic Information
9.11.2 KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Product Overview
9.11.3 KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Product Market Performance
9.11.4 KoninklijikePhilips N.V. Business Overview
9.11.5 KoninklijikePhilips N.V. Recent Developments
9.12 GE Healthcare Bio Sciences AB
9.12.1 GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Basic Information
9.12.2 GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Product Overview
9.12.3 GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Product Market Performance
9.12.4 GE Healthcare Bio Sciences AB Business Overview
9.12.5 GE Healthcare Bio Sciences AB Recent Developments
9.13 Quest Diagnostics lIncorporated
9.13.1 Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Basic Information
9.13.2 Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Product Overview
9.13.3 Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Product Market Performance
9.13.4 Quest Diagnostics lIncorporated Business Overview
9.13.5 Quest Diagnostics lIncorporated Recent Developments
9.14 Agilent Technologies lnc
9.14.1 Agilent Technologies lnc Lung Cancer Diagnostic And Screening Basic Information
9.14.2 Agilent Technologies lnc Lung Cancer Diagnostic And Screening Product Overview
9.14.3 Agilent Technologies lnc Lung Cancer Diagnostic And Screening Product Market Performance
9.14.4 Agilent Technologies lnc Business Overview
9.14.5 Agilent Technologies lnc Recent Developments
9.15 Qiagen Inc.
9.15.1 Qiagen Inc. Lung Cancer Diagnostic And Screening Basic Information
9.15.2 Qiagen Inc. Lung Cancer Diagnostic And Screening Product Overview
9.15.3 Qiagen Inc. Lung Cancer Diagnostic And Screening Product Market Performance
9.15.4 Qiagen Inc. Business Overview
9.15.5 Qiagen Inc. Recent Developments
9.16 Myriad Genetic Laboratories Inc.
9.16.1 Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Basic Information
9.16.2 Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Product Overview
9.16.3 Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Product Market Performance
9.16.4 Myriad Genetic Laboratories Inc. Business Overview
9.16.5 Myriad Genetic Laboratories Inc. Recent Developments
9.17 NeoGenomics Laboratories Inc
9.17.1 NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Basic Information
9.17.2 NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Product Overview
9.17.3 NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Product Market Performance
9.17.4 NeoGenomics Laboratories Inc Business Overview
9.17.5 NeoGenomics Laboratories Inc Recent Developments
9.18 Canon MedicalSystems Corporation
9.18.1 Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Basic Information
9.18.2 Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Product Overview
9.18.3 Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Product Market Performance
9.18.4 Canon MedicalSystems Corporation Business Overview
9.18.5 Canon MedicalSystems Corporation Recent Developments
9.19 Eon Health Inc
9.19.1 Eon Health Inc Lung Cancer Diagnostic And Screening Basic Information
9.19.2 Eon Health Inc Lung Cancer Diagnostic And Screening Product Overview
9.19.3 Eon Health Inc Lung Cancer Diagnostic And Screening Product Market Performance
9.19.4 Eon Health Inc Business Overview
9.19.5 Eon Health Inc Recent Developments
10 LUNG CANCER DIAGNOSTIC AND SCREENING REGIONAL MARKET FORECAST
10.1 Global Lung Cancer Diagnostic And Screening Market Size Forecast
10.2 Global Lung Cancer Diagnostic And Screening Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Lung Cancer Diagnostic And Screening Market Size Forecast by Country
10.2.3 Asia Pacific Lung Cancer Diagnostic And Screening Market Size Forecast by Region
10.2.4 South America Lung Cancer Diagnostic And Screening Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Lung Cancer Diagnostic And Screening by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Lung Cancer Diagnostic And Screening Market Forecast by Type (2025-2030)
11.2 Global Lung Cancer Diagnostic And Screening Market Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Lung Cancer Diagnostic And Screening
1.2 Key Market Segments
1.2.1 Lung Cancer Diagnostic And Screening Segment by Type
1.2.2 Lung Cancer Diagnostic And Screening Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LUNG CANCER DIAGNOSTIC AND SCREENING MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LUNG CANCER DIAGNOSTIC AND SCREENING MARKET COMPETITIVE LANDSCAPE
3.1 Global Lung Cancer Diagnostic And Screening Revenue Market Share by Company (2019-2024)
3.2 Lung Cancer Diagnostic And Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Lung Cancer Diagnostic And Screening Market Size Sites, Area Served, Product Type
3.4 Lung Cancer Diagnostic And Screening Market Competitive Situation and Trends
3.4.1 Lung Cancer Diagnostic And Screening Market Concentration Rate
3.4.2 Global 5 and 10 Largest Lung Cancer Diagnostic And Screening Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 LUNG CANCER DIAGNOSTIC AND SCREENING VALUE CHAIN ANALYSIS
4.1 Lung Cancer Diagnostic And Screening Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LUNG CANCER DIAGNOSTIC AND SCREENING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 LUNG CANCER DIAGNOSTIC AND SCREENING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Diagnostic And Screening Market Size Market Share by Type (2019-2024)
6.3 Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Type (2019-2024)
7 LUNG CANCER DIAGNOSTIC AND SCREENING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Diagnostic And Screening Market Size (M USD) by Application (2019-2024)
7.3 Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Application (2019-2024)
8 LUNG CANCER DIAGNOSTIC AND SCREENING MARKET SEGMENTATION BY REGION
8.1 Global Lung Cancer Diagnostic And Screening Market Size by Region
8.1.1 Global Lung Cancer Diagnostic And Screening Market Size by Region
8.1.2 Global Lung Cancer Diagnostic And Screening Market Size Market Share by Region
8.2 North America
8.2.1 North America Lung Cancer Diagnostic And Screening Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Lung Cancer Diagnostic And Screening Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Lung Cancer Diagnostic And Screening Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Lung Cancer Diagnostic And Screening Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Lung Cancer Diagnostic And Screening Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer Lung Cancer Diagnostic And Screening Basic Information
9.1.2 Pfizer Lung Cancer Diagnostic And Screening Product Overview
9.1.3 Pfizer Lung Cancer Diagnostic And Screening Product Market Performance
9.1.4 Pfizer Lung Cancer Diagnostic And Screening SWOT Analysis
9.1.5 Pfizer Business Overview
9.1.6 Pfizer Recent Developments
9.2 F.Hoffmann-La Roche AG
9.2.1 F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Basic Information
9.2.2 F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Product Overview
9.2.3 F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Product Market Performance
9.2.4 Pfizer Lung Cancer Diagnostic And Screening SWOT Analysis
9.2.5 F.Hoffmann-La Roche AG Business Overview
9.2.6 F.Hoffmann-La Roche AG Recent Developments
9.3 Bristol-Myers Squibb Company
9.3.1 Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Basic Information
9.3.2 Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Product Overview
9.3.3 Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Product Market Performance
9.3.4 Pfizer Lung Cancer Diagnostic And Screening SWOT Analysis
9.3.5 Bristol-Myers Squibb Company Business Overview
9.3.6 Bristol-Myers Squibb Company Recent Developments
9.4 Thermo Fisher Scientific
9.4.1 Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Basic Information
9.4.2 Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Product Overview
9.4.3 Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Product Market Performance
9.4.4 Thermo Fisher Scientific Business Overview
9.4.5 Thermo Fisher Scientific Recent Developments
9.5 AstraZeneca Plc
9.5.1 AstraZeneca Plc Lung Cancer Diagnostic And Screening Basic Information
9.5.2 AstraZeneca Plc Lung Cancer Diagnostic And Screening Product Overview
9.5.3 AstraZeneca Plc Lung Cancer Diagnostic And Screening Product Market Performance
9.5.4 AstraZeneca Plc Business Overview
9.5.5 AstraZeneca Plc Recent Developments
9.6 Abbott Laboratories
9.6.1 Abbott Laboratories Lung Cancer Diagnostic And Screening Basic Information
9.6.2 Abbott Laboratories Lung Cancer Diagnostic And Screening Product Overview
9.6.3 Abbott Laboratories Lung Cancer Diagnostic And Screening Product Market Performance
9.6.4 Abbott Laboratories Business Overview
9.6.5 Abbott Laboratories Recent Developments
9.7 Medtronic Plc
9.7.1 Medtronic Plc Lung Cancer Diagnostic And Screening Basic Information
9.7.2 Medtronic Plc Lung Cancer Diagnostic And Screening Product Overview
9.7.3 Medtronic Plc Lung Cancer Diagnostic And Screening Product Market Performance
9.7.4 Medtronic Plc Business Overview
9.7.5 Medtronic Plc Recent Developments
9.8 Danaher Corporation
9.8.1 Danaher Corporation Lung Cancer Diagnostic And Screening Basic Information
9.8.2 Danaher Corporation Lung Cancer Diagnostic And Screening Product Overview
9.8.3 Danaher Corporation Lung Cancer Diagnostic And Screening Product Market Performance
9.8.4 Danaher Corporation Business Overview
9.8.5 Danaher Corporation Recent Developments
9.9 Siemens Healthcare GmbH
9.9.1 Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Basic Information
9.9.2 Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Product Overview
9.9.3 Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Product Market Performance
9.9.4 Siemens Healthcare GmbH Business Overview
9.9.5 Siemens Healthcare GmbH Recent Developments
9.10 FUJIFILM Corporation
9.10.1 FUJIFILM Corporation Lung Cancer Diagnostic And Screening Basic Information
9.10.2 FUJIFILM Corporation Lung Cancer Diagnostic And Screening Product Overview
9.10.3 FUJIFILM Corporation Lung Cancer Diagnostic And Screening Product Market Performance
9.10.4 FUJIFILM Corporation Business Overview
9.10.5 FUJIFILM Corporation Recent Developments
9.11 KoninklijikePhilips N.V.
9.11.1 KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Basic Information
9.11.2 KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Product Overview
9.11.3 KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Product Market Performance
9.11.4 KoninklijikePhilips N.V. Business Overview
9.11.5 KoninklijikePhilips N.V. Recent Developments
9.12 GE Healthcare Bio Sciences AB
9.12.1 GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Basic Information
9.12.2 GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Product Overview
9.12.3 GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Product Market Performance
9.12.4 GE Healthcare Bio Sciences AB Business Overview
9.12.5 GE Healthcare Bio Sciences AB Recent Developments
9.13 Quest Diagnostics lIncorporated
9.13.1 Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Basic Information
9.13.2 Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Product Overview
9.13.3 Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Product Market Performance
9.13.4 Quest Diagnostics lIncorporated Business Overview
9.13.5 Quest Diagnostics lIncorporated Recent Developments
9.14 Agilent Technologies lnc
9.14.1 Agilent Technologies lnc Lung Cancer Diagnostic And Screening Basic Information
9.14.2 Agilent Technologies lnc Lung Cancer Diagnostic And Screening Product Overview
9.14.3 Agilent Technologies lnc Lung Cancer Diagnostic And Screening Product Market Performance
9.14.4 Agilent Technologies lnc Business Overview
9.14.5 Agilent Technologies lnc Recent Developments
9.15 Qiagen Inc.
9.15.1 Qiagen Inc. Lung Cancer Diagnostic And Screening Basic Information
9.15.2 Qiagen Inc. Lung Cancer Diagnostic And Screening Product Overview
9.15.3 Qiagen Inc. Lung Cancer Diagnostic And Screening Product Market Performance
9.15.4 Qiagen Inc. Business Overview
9.15.5 Qiagen Inc. Recent Developments
9.16 Myriad Genetic Laboratories Inc.
9.16.1 Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Basic Information
9.16.2 Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Product Overview
9.16.3 Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Product Market Performance
9.16.4 Myriad Genetic Laboratories Inc. Business Overview
9.16.5 Myriad Genetic Laboratories Inc. Recent Developments
9.17 NeoGenomics Laboratories Inc
9.17.1 NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Basic Information
9.17.2 NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Product Overview
9.17.3 NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Product Market Performance
9.17.4 NeoGenomics Laboratories Inc Business Overview
9.17.5 NeoGenomics Laboratories Inc Recent Developments
9.18 Canon MedicalSystems Corporation
9.18.1 Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Basic Information
9.18.2 Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Product Overview
9.18.3 Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Product Market Performance
9.18.4 Canon MedicalSystems Corporation Business Overview
9.18.5 Canon MedicalSystems Corporation Recent Developments
9.19 Eon Health Inc
9.19.1 Eon Health Inc Lung Cancer Diagnostic And Screening Basic Information
9.19.2 Eon Health Inc Lung Cancer Diagnostic And Screening Product Overview
9.19.3 Eon Health Inc Lung Cancer Diagnostic And Screening Product Market Performance
9.19.4 Eon Health Inc Business Overview
9.19.5 Eon Health Inc Recent Developments
10 LUNG CANCER DIAGNOSTIC AND SCREENING REGIONAL MARKET FORECAST
10.1 Global Lung Cancer Diagnostic And Screening Market Size Forecast
10.2 Global Lung Cancer Diagnostic And Screening Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Lung Cancer Diagnostic And Screening Market Size Forecast by Country
10.2.3 Asia Pacific Lung Cancer Diagnostic And Screening Market Size Forecast by Region
10.2.4 South America Lung Cancer Diagnostic And Screening Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Lung Cancer Diagnostic And Screening by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Lung Cancer Diagnostic And Screening Market Forecast by Type (2025-2030)
11.2 Global Lung Cancer Diagnostic And Screening Market Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Lung Cancer Diagnostic And Screening Market Size Comparison by Region (M USD)
Table 5. Global Lung Cancer Diagnostic And Screening Revenue (M USD) by Company (2019-2024)
Table 6. Global Lung Cancer Diagnostic And Screening Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Diagnostic And Screening as of 2022)
Table 8. Company Lung Cancer Diagnostic And Screening Market Size Sites and Area Served
Table 9. Company Lung Cancer Diagnostic And Screening Product Type
Table 10. Global Lung Cancer Diagnostic And Screening Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Lung Cancer Diagnostic And Screening
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Lung Cancer Diagnostic And Screening Market Challenges
Table 18. Global Lung Cancer Diagnostic And Screening Market Size by Type (M USD)
Table 19. Global Lung Cancer Diagnostic And Screening Market Size (M USD) by Type (2019-2024)
Table 20. Global Lung Cancer Diagnostic And Screening Market Size Share by Type (2019-2024)
Table 21. Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Type (2019-2024)
Table 22. Global Lung Cancer Diagnostic And Screening Market Size by Application
Table 23. Global Lung Cancer Diagnostic And Screening Market Size by Application (2019-2024) & (M USD)
Table 24. Global Lung Cancer Diagnostic And Screening Market Share by Application (2019-2024)
Table 25. Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Application (2019-2024)
Table 26. Global Lung Cancer Diagnostic And Screening Market Size by Region (2019-2024) & (M USD)
Table 27. Global Lung Cancer Diagnostic And Screening Market Size Market Share by Region (2019-2024)
Table 28. North America Lung Cancer Diagnostic And Screening Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Lung Cancer Diagnostic And Screening Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Lung Cancer Diagnostic And Screening Market Size by Region (2019-2024) & (M USD)
Table 31. South America Lung Cancer Diagnostic And Screening Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Lung Cancer Diagnostic And Screening Market Size by Region (2019-2024) & (M USD)
Table 33. Pfizer Lung Cancer Diagnostic And Screening Basic Information
Table 34. Pfizer Lung Cancer Diagnostic And Screening Product Overview
Table 35. Pfizer Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 36. Pfizer Lung Cancer Diagnostic And Screening SWOT Analysis
Table 37. Pfizer Business Overview
Table 38. Pfizer Recent Developments
Table 39. F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Basic Information
Table 40. F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Product Overview
Table 41. F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 42. Pfizer Lung Cancer Diagnostic And Screening SWOT Analysis
Table 43. F.Hoffmann-La Roche AG Business Overview
Table 44. F.Hoffmann-La Roche AG Recent Developments
Table 45. Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Basic Information
Table 46. Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Product Overview
Table 47. Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 48. Pfizer Lung Cancer Diagnostic And Screening SWOT Analysis
Table 49. Bristol-Myers Squibb Company Business Overview
Table 50. Bristol-Myers Squibb Company Recent Developments
Table 51. Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Basic Information
Table 52. Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Product Overview
Table 53. Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 54. Thermo Fisher Scientific Business Overview
Table 55. Thermo Fisher Scientific Recent Developments
Table 56. AstraZeneca Plc Lung Cancer Diagnostic And Screening Basic Information
Table 57. AstraZeneca Plc Lung Cancer Diagnostic And Screening Product Overview
Table 58. AstraZeneca Plc Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 59. AstraZeneca Plc Business Overview
Table 60. AstraZeneca Plc Recent Developments
Table 61. Abbott Laboratories Lung Cancer Diagnostic And Screening Basic Information
Table 62. Abbott Laboratories Lung Cancer Diagnostic And Screening Product Overview
Table 63. Abbott Laboratories Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories Recent Developments
Table 66. Medtronic Plc Lung Cancer Diagnostic And Screening Basic Information
Table 67. Medtronic Plc Lung Cancer Diagnostic And Screening Product Overview
Table 68. Medtronic Plc Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Medtronic Plc Business Overview
Table 70. Medtronic Plc Recent Developments
Table 71. Danaher Corporation Lung Cancer Diagnostic And Screening Basic Information
Table 72. Danaher Corporation Lung Cancer Diagnostic And Screening Product Overview
Table 73. Danaher Corporation Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Danaher Corporation Business Overview
Table 75. Danaher Corporation Recent Developments
Table 76. Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Basic Information
Table 77. Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Product Overview
Table 78. Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 79. Siemens Healthcare GmbH Business Overview
Table 80. Siemens Healthcare GmbH Recent Developments
Table 81. FUJIFILM Corporation Lung Cancer Diagnostic And Screening Basic Information
Table 82. FUJIFILM Corporation Lung Cancer Diagnostic And Screening Product Overview
Table 83. FUJIFILM Corporation Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 84. FUJIFILM Corporation Business Overview
Table 85. FUJIFILM Corporation Recent Developments
Table 86. KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Basic Information
Table 87. KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Product Overview
Table 88. KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 89. KoninklijikePhilips N.V. Business Overview
Table 90. KoninklijikePhilips N.V. Recent Developments
Table 91. GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Basic Information
Table 92. GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Product Overview
Table 93. GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 94. GE Healthcare Bio Sciences AB Business Overview
Table 95. GE Healthcare Bio Sciences AB Recent Developments
Table 96. Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Basic Information
Table 97. Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Product Overview
Table 98. Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 99. Quest Diagnostics lIncorporated Business Overview
Table 100. Quest Diagnostics lIncorporated Recent Developments
Table 101. Agilent Technologies lnc Lung Cancer Diagnostic And Screening Basic Information
Table 102. Agilent Technologies lnc Lung Cancer Diagnostic And Screening Product Overview
Table 103. Agilent Technologies lnc Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 104. Agilent Technologies lnc Business Overview
Table 105. Agilent Technologies lnc Recent Developments
Table 106. Qiagen Inc. Lung Cancer Diagnostic And Screening Basic Information
Table 107. Qiagen Inc. Lung Cancer Diagnostic And Screening Product Overview
Table 108. Qiagen Inc. Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 109. Qiagen Inc. Business Overview
Table 110. Qiagen Inc. Recent Developments
Table 111. Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Basic Information
Table 112. Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Product Overview
Table 113. Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 114. Myriad Genetic Laboratories Inc. Business Overview
Table 115. Myriad Genetic Laboratories Inc. Recent Developments
Table 116. NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Basic Information
Table 117. NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Product Overview
Table 118. NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 119. NeoGenomics Laboratories Inc Business Overview
Table 120. NeoGenomics Laboratories Inc Recent Developments
Table 121. Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Basic Information
Table 122. Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Product Overview
Table 123. Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 124. Canon MedicalSystems Corporation Business Overview
Table 125. Canon MedicalSystems Corporation Recent Developments
Table 126. Eon Health Inc Lung Cancer Diagnostic And Screening Basic Information
Table 127. Eon Health Inc Lung Cancer Diagnostic And Screening Product Overview
Table 128. Eon Health Inc Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 129. Eon Health Inc Business Overview
Table 130. Eon Health Inc Recent Developments
Table 131. Global Lung Cancer Diagnostic And Screening Market Size Forecast by Region (2025-2030) & (M USD)
Table 132. North America Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Europe Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2025-2030) & (M USD)
Table 134. Asia Pacific Lung Cancer Diagnostic And Screening Market Size Forecast by Region (2025-2030) & (M USD)
Table 135. South America Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Global Lung Cancer Diagnostic And Screening Market Size Forecast by Type (2025-2030) & (M USD)
Table 138. Global Lung Cancer Diagnostic And Screening Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Lung Cancer Diagnostic And Screening Market Size Comparison by Region (M USD)
Table 5. Global Lung Cancer Diagnostic And Screening Revenue (M USD) by Company (2019-2024)
Table 6. Global Lung Cancer Diagnostic And Screening Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Diagnostic And Screening as of 2022)
Table 8. Company Lung Cancer Diagnostic And Screening Market Size Sites and Area Served
Table 9. Company Lung Cancer Diagnostic And Screening Product Type
Table 10. Global Lung Cancer Diagnostic And Screening Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Lung Cancer Diagnostic And Screening
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Lung Cancer Diagnostic And Screening Market Challenges
Table 18. Global Lung Cancer Diagnostic And Screening Market Size by Type (M USD)
Table 19. Global Lung Cancer Diagnostic And Screening Market Size (M USD) by Type (2019-2024)
Table 20. Global Lung Cancer Diagnostic And Screening Market Size Share by Type (2019-2024)
Table 21. Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Type (2019-2024)
Table 22. Global Lung Cancer Diagnostic And Screening Market Size by Application
Table 23. Global Lung Cancer Diagnostic And Screening Market Size by Application (2019-2024) & (M USD)
Table 24. Global Lung Cancer Diagnostic And Screening Market Share by Application (2019-2024)
Table 25. Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Application (2019-2024)
Table 26. Global Lung Cancer Diagnostic And Screening Market Size by Region (2019-2024) & (M USD)
Table 27. Global Lung Cancer Diagnostic And Screening Market Size Market Share by Region (2019-2024)
Table 28. North America Lung Cancer Diagnostic And Screening Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Lung Cancer Diagnostic And Screening Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Lung Cancer Diagnostic And Screening Market Size by Region (2019-2024) & (M USD)
Table 31. South America Lung Cancer Diagnostic And Screening Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Lung Cancer Diagnostic And Screening Market Size by Region (2019-2024) & (M USD)
Table 33. Pfizer Lung Cancer Diagnostic And Screening Basic Information
Table 34. Pfizer Lung Cancer Diagnostic And Screening Product Overview
Table 35. Pfizer Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 36. Pfizer Lung Cancer Diagnostic And Screening SWOT Analysis
Table 37. Pfizer Business Overview
Table 38. Pfizer Recent Developments
Table 39. F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Basic Information
Table 40. F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Product Overview
Table 41. F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 42. Pfizer Lung Cancer Diagnostic And Screening SWOT Analysis
Table 43. F.Hoffmann-La Roche AG Business Overview
Table 44. F.Hoffmann-La Roche AG Recent Developments
Table 45. Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Basic Information
Table 46. Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Product Overview
Table 47. Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 48. Pfizer Lung Cancer Diagnostic And Screening SWOT Analysis
Table 49. Bristol-Myers Squibb Company Business Overview
Table 50. Bristol-Myers Squibb Company Recent Developments
Table 51. Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Basic Information
Table 52. Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Product Overview
Table 53. Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 54. Thermo Fisher Scientific Business Overview
Table 55. Thermo Fisher Scientific Recent Developments
Table 56. AstraZeneca Plc Lung Cancer Diagnostic And Screening Basic Information
Table 57. AstraZeneca Plc Lung Cancer Diagnostic And Screening Product Overview
Table 58. AstraZeneca Plc Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 59. AstraZeneca Plc Business Overview
Table 60. AstraZeneca Plc Recent Developments
Table 61. Abbott Laboratories Lung Cancer Diagnostic And Screening Basic Information
Table 62. Abbott Laboratories Lung Cancer Diagnostic And Screening Product Overview
Table 63. Abbott Laboratories Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories Recent Developments
Table 66. Medtronic Plc Lung Cancer Diagnostic And Screening Basic Information
Table 67. Medtronic Plc Lung Cancer Diagnostic And Screening Product Overview
Table 68. Medtronic Plc Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Medtronic Plc Business Overview
Table 70. Medtronic Plc Recent Developments
Table 71. Danaher Corporation Lung Cancer Diagnostic And Screening Basic Information
Table 72. Danaher Corporation Lung Cancer Diagnostic And Screening Product Overview
Table 73. Danaher Corporation Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Danaher Corporation Business Overview
Table 75. Danaher Corporation Recent Developments
Table 76. Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Basic Information
Table 77. Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Product Overview
Table 78. Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 79. Siemens Healthcare GmbH Business Overview
Table 80. Siemens Healthcare GmbH Recent Developments
Table 81. FUJIFILM Corporation Lung Cancer Diagnostic And Screening Basic Information
Table 82. FUJIFILM Corporation Lung Cancer Diagnostic And Screening Product Overview
Table 83. FUJIFILM Corporation Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 84. FUJIFILM Corporation Business Overview
Table 85. FUJIFILM Corporation Recent Developments
Table 86. KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Basic Information
Table 87. KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Product Overview
Table 88. KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 89. KoninklijikePhilips N.V. Business Overview
Table 90. KoninklijikePhilips N.V. Recent Developments
Table 91. GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Basic Information
Table 92. GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Product Overview
Table 93. GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 94. GE Healthcare Bio Sciences AB Business Overview
Table 95. GE Healthcare Bio Sciences AB Recent Developments
Table 96. Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Basic Information
Table 97. Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Product Overview
Table 98. Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 99. Quest Diagnostics lIncorporated Business Overview
Table 100. Quest Diagnostics lIncorporated Recent Developments
Table 101. Agilent Technologies lnc Lung Cancer Diagnostic And Screening Basic Information
Table 102. Agilent Technologies lnc Lung Cancer Diagnostic And Screening Product Overview
Table 103. Agilent Technologies lnc Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 104. Agilent Technologies lnc Business Overview
Table 105. Agilent Technologies lnc Recent Developments
Table 106. Qiagen Inc. Lung Cancer Diagnostic And Screening Basic Information
Table 107. Qiagen Inc. Lung Cancer Diagnostic And Screening Product Overview
Table 108. Qiagen Inc. Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 109. Qiagen Inc. Business Overview
Table 110. Qiagen Inc. Recent Developments
Table 111. Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Basic Information
Table 112. Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Product Overview
Table 113. Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 114. Myriad Genetic Laboratories Inc. Business Overview
Table 115. Myriad Genetic Laboratories Inc. Recent Developments
Table 116. NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Basic Information
Table 117. NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Product Overview
Table 118. NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 119. NeoGenomics Laboratories Inc Business Overview
Table 120. NeoGenomics Laboratories Inc Recent Developments
Table 121. Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Basic Information
Table 122. Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Product Overview
Table 123. Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 124. Canon MedicalSystems Corporation Business Overview
Table 125. Canon MedicalSystems Corporation Recent Developments
Table 126. Eon Health Inc Lung Cancer Diagnostic And Screening Basic Information
Table 127. Eon Health Inc Lung Cancer Diagnostic And Screening Product Overview
Table 128. Eon Health Inc Lung Cancer Diagnostic And Screening Revenue (M USD) and Gross Margin (2019-2024)
Table 129. Eon Health Inc Business Overview
Table 130. Eon Health Inc Recent Developments
Table 131. Global Lung Cancer Diagnostic And Screening Market Size Forecast by Region (2025-2030) & (M USD)
Table 132. North America Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Europe Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2025-2030) & (M USD)
Table 134. Asia Pacific Lung Cancer Diagnostic And Screening Market Size Forecast by Region (2025-2030) & (M USD)
Table 135. South America Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Global Lung Cancer Diagnostic And Screening Market Size Forecast by Type (2025-2030) & (M USD)
Table 138. Global Lung Cancer Diagnostic And Screening Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Industrial Chain of Lung Cancer Diagnostic And Screening
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lung Cancer Diagnostic And Screening Market Size (M USD), 2019-2030
Figure 5. Global Lung Cancer Diagnostic And Screening Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Lung Cancer Diagnostic And Screening Market Size by Country (M USD)
Figure 10. Global Lung Cancer Diagnostic And Screening Revenue Share by Company in 2023
Figure 11. Lung Cancer Diagnostic And Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Lung Cancer Diagnostic And Screening Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Lung Cancer Diagnostic And Screening Market Share by Type
Figure 15. Market Size Share of Lung Cancer Diagnostic And Screening by Type (2019-2024)
Figure 16. Market Size Market Share of Lung Cancer Diagnostic And Screening by Type in 2022
Figure 17. Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Lung Cancer Diagnostic And Screening Market Share by Application
Figure 20. Global Lung Cancer Diagnostic And Screening Market Share by Application (2019-2024)
Figure 21. Global Lung Cancer Diagnostic And Screening Market Share by Application in 2022
Figure 22. Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Lung Cancer Diagnostic And Screening Market Size Market Share by Region (2019-2024)
Figure 24. North America Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Lung Cancer Diagnostic And Screening Market Size Market Share by Country in 2023
Figure 26. U.S. Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Lung Cancer Diagnostic And Screening Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Lung Cancer Diagnostic And Screening Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Lung Cancer Diagnostic And Screening Market Size Market Share by Country in 2023
Figure 31. Germany Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Lung Cancer Diagnostic And Screening Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Lung Cancer Diagnostic And Screening Market Size Market Share by Region in 2023
Figure 38. China Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Lung Cancer Diagnostic And Screening Market Size and Growth Rate (M USD)
Figure 44. South America Lung Cancer Diagnostic And Screening Market Size Market Share by Country in 2023
Figure 45. Brazil Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Lung Cancer Diagnostic And Screening Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Lung Cancer Diagnostic And Screening Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Lung Cancer Diagnostic And Screening Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Lung Cancer Diagnostic And Screening Market Share Forecast by Type (2025-2030)
Figure 57. Global Lung Cancer Diagnostic And Screening Market Share Forecast by Application (2025-2030)
Figure 1. Industrial Chain of Lung Cancer Diagnostic And Screening
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lung Cancer Diagnostic And Screening Market Size (M USD), 2019-2030
Figure 5. Global Lung Cancer Diagnostic And Screening Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Lung Cancer Diagnostic And Screening Market Size by Country (M USD)
Figure 10. Global Lung Cancer Diagnostic And Screening Revenue Share by Company in 2023
Figure 11. Lung Cancer Diagnostic And Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Lung Cancer Diagnostic And Screening Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Lung Cancer Diagnostic And Screening Market Share by Type
Figure 15. Market Size Share of Lung Cancer Diagnostic And Screening by Type (2019-2024)
Figure 16. Market Size Market Share of Lung Cancer Diagnostic And Screening by Type in 2022
Figure 17. Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Lung Cancer Diagnostic And Screening Market Share by Application
Figure 20. Global Lung Cancer Diagnostic And Screening Market Share by Application (2019-2024)
Figure 21. Global Lung Cancer Diagnostic And Screening Market Share by Application in 2022
Figure 22. Global Lung Cancer Diagnostic And Screening Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Lung Cancer Diagnostic And Screening Market Size Market Share by Region (2019-2024)
Figure 24. North America Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Lung Cancer Diagnostic And Screening Market Size Market Share by Country in 2023
Figure 26. U.S. Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Lung Cancer Diagnostic And Screening Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Lung Cancer Diagnostic And Screening Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Lung Cancer Diagnostic And Screening Market Size Market Share by Country in 2023
Figure 31. Germany Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Lung Cancer Diagnostic And Screening Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Lung Cancer Diagnostic And Screening Market Size Market Share by Region in 2023
Figure 38. China Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Lung Cancer Diagnostic And Screening Market Size and Growth Rate (M USD)
Figure 44. South America Lung Cancer Diagnostic And Screening Market Size Market Share by Country in 2023
Figure 45. Brazil Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Lung Cancer Diagnostic And Screening Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Lung Cancer Diagnostic And Screening Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Lung Cancer Diagnostic And Screening Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Lung Cancer Diagnostic And Screening Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Lung Cancer Diagnostic And Screening Market Share Forecast by Type (2025-2030)
Figure 57. Global Lung Cancer Diagnostic And Screening Market Share Forecast by Application (2025-2030)
